Citigroup analyst Andrew Kaplowitz maintains Flowserve (NYSE:FLS) with a Buy and raises the price target from $32 to $36.
Raymond James Maintains Outperform on Merit Medical Systems, Raises Price Target to $80
Raymond James analyst Jayson Bedford maintains Merit Medical Systems (NASDAQ:MMSI) with a Outperform and raises the price target from $72 to $80.